Recently, this mechanism has been the focus of attention in patients with CRC, and the albumin/globulin ratio is reported to be useful for prognostication in such patients.10 We have also reported that the globulin‐to‐albumin ratio (GAR) is a useful predictor of postoperative survival in patients with hepatocellular carcinoma (HCC) undergoing potentially curative liver resection.11 Because the GAR is the ratio of albumin relative to globulin, it is less affected by measurement variability and can be determined as easily as the NLR. This evidence concerns the gene ALB and hepatocellular carcinoma.